Brian Jg Pereira - 12 Nov 2025 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Role
Director
Signature
/s/ Todd Girolamo, attorney in fact
Issuer symbol
PROK
Transactions as of
12 Nov 2025
Net transactions value
-$1,884,577
Form type
4
Filing time
14 Nov 2025, 16:07:02 UTC
Previous filing
02 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pereira Brian JG Director C/O PROKIDNEY CORP, 2000 FRONTIS PLAZA BLVD, SUITE 250, WINSTON SALEM /s/ Todd Girolamo, attorney in fact 14 Nov 2025 0001298146

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PROK Class A Common Stock Sale $619,363 -227,431 -34% $2.72 447,803 12 Nov 2025 By Brian J. G. Pereira 2012 Irrevocable Trust F1
transaction PROK Class A Common Stock Sale $75,152 -27,595 -34% $2.72 54,333 12 Nov 2025 Brian J. G. Pereira 2004 Trust F1
transaction PROK Class A Common Stock Sale $1,061,293 -447,803 -100% $2.37 0 13 Nov 2025 By Brian J. G. Pereira 2012 Irrevocable Trust F2
transaction PROK Class A Common Stock Sale $128,769 -54,333 -100% $2.37 0 13 Nov 2025 Brian J. G. Pereira 2004 Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.88, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.66, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote